Interestingly, the reduction in OXPHOS and impaired glucose responsiveness was also observed in the myoblast cell line H9C2 with a mutation in the bone morphogenetic protein receptor type 2 (BMPR2) [112], which is related to genetic PAH. Here, BMPR2 is linked to pulmonary arterial hypertension.